[LGND] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 94.18%
YoY- -102.91%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 43,979 50,382 66,088 57,419 45,693 72,473 64,835 -22.81%
PBT 55,536 24,140 857 -636 -20,140 -7,026 15,259 136.79%
Tax 11,922 38,674 453 259 -4,755 -2,058 1,536 292.50%
NP 41,949 -14,534 404 -895 -15,385 -4,968 13,723 110.77%
Tax Rate -21.47% -160.21% -52.86% - - - -10.07% -
Total Cost 2,030 64,916 65,684 58,314 61,078 77,441 51,112 -88.38%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 95.38 -28.85 0.61 -1.56 -33.67 -6.85 21.17 173.03%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS 2.46 -0.86 0.02 -0.05 -0.92 -0.30 0.82 108.14%
EPS Diluted 2.33 -0.86 0.02 -0.05 -0.91 -0.30 0.80 104.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.